Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mylan Generic Isotretinoin Risk Program To Use BU’s Slone Epidemiology

Executive Summary

Mylan generic isotretinoin risk management will be conducted at the Slone Epidemiology Unit of Boston University School of Public Health, the same institution Roche has been using for its risk management program for Accutane
Advertisement

Related Content

Cardinal Manufacturing Helped By FDA Compliance Crackdown, Firm Says
Cardinal Manufacturing Helped By FDA Compliance Crackdown, Firm Says
Mylan Generic Isotretinoin Price Will Be 90% Of Roche Accutane AWP
Mylan Generic Isotretinoin Price Will Be 90% Of Roche Accutane AWP
Mylan Generic Accutane Forecast Assumes May/June Launch
Mylan Generic Accutane Forecast Assumes May/June Launch
Roche Accutane Generic Forecast Assumes Hesitancy To Switch Risk Plans
Accutane Generics Need Separate Risk Management Programs, Roche Says
Advertisement
UsernamePublicRestriction

Register

PS040773

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel